Drug Type Recombinant protein |
Synonyms ADC-1012 |
Target |
Mechanism IL-23 inhibitors(Interleukin-23 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | SE | - | |
Neoplasms | Discovery | SE | - |